MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
about
Immunotherapy of Dual-Function Vector with Both Immunostimulatory and B-Cell Lymphoma 2 (Bcl-2)-Silencing Effects on Gastric Carcinoma.The metastasis suppressor gene KISS-1 regulates osteosarcoma apoptosis and autophagy processesNoncoding RNA in drug resistant sarcoma.miR-200bc/429 Inhibits Osteosarcoma Cell Proliferation and Invasion by Targeting PMP22.Decreased WWOX expression promotes angiogenesis in osteosarcoma.lncRNA UCA1 Is a Novel Regulator in Cardiomyocyte Hypertrophy through Targeting the miR-184/HOXA9 Axis.MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1.Regulatory effects of microRNA‑184 on osteosarcoma via the Wnt/β‑catenin signaling pathwayLong Non-Coding RNA HULC Promotes Progression of Bone Neoplasms
P2860
Q33626347-343F6533-8357-450C-A7EF-D553A7CB4E11Q38721962-A46992CF-15E4-4615-A74E-7D612DBACB3CQ41924654-9A7A4949-654F-4A03-B6EA-55208A4836FEQ42318103-3D65E1A9-E556-470C-B2A1-F1C1092DBA65Q42365252-9786402A-0F2B-4BD6-BF0A-72137E27D2A1Q52607839-EC50D923-BC14-4B97-A221-EADAE1AD768CQ55492687-B5A76FB2-C5C2-4FCD-B635-44DBDF316D14Q57173163-8D469A3C-41FA-4F32-940B-43C9DD1D9E3EQ58766881-309D12B6-5BC4-4D7E-827D-C2A062471024
P2860
MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
@en
type
label
MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
@en
prefLabel
MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
@en
P2093
P2860
P356
P1476
MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
@en
P2093
Bo-Chuan Lin
Chao-Qun Yu
Da-Wei Zhang
Dong Huang
Feng-Jun Shi
Yuan-Hang Liu
P2860
P304
P356
10.12659/MSM.896451
P577
2016-05-25T00:00:00Z